Q2 2022 Xeris Biopharma Holdings Inc Earnings Call Transcript
Hello, and welcome to today's Xeris Biopharma Second Quarter 2022 Financial Results Call. My name is Elliot, and I'll be coordinating your call today. (Operator Instructions) I would now like to hand over to Allison Wey, Senior Vice President of Investor Relations and Corporate Communications. The floor is yours. Please go ahead.
Thank you, Elliot. Good morning, and welcome to Xeris Biopharma's Second Quarter 2022 Financial Results and Corporate Update Conference Call and Webcast. A press release with the company's second quarter 2022 financial results was issued earlier this morning and can be found on our website.
We are joined this morning by Paul Edick, Chairman and CEO; and Steve Pieper, our CFO. Paul will provide opening remarks, Steve will provide details on our financial results, and then we will open the call for questions.
Before we would begin, I would like to remind you that this call will contain forward-looking statements concerning Xeris'
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |